Organization
Appili Therapeutics
2 clinical trials
Clinical trial
Favipiravir for Patients With Mild to Moderate Disease From Novel Coronavirus (COVID-19)Status: Completed, Estimated PCD: 2021-10-20
Clinical trial
Control of COVID-19 Outbreaks in Long Term Care (CONTROL-COVID)Status: Terminated, Estimated PCD: 2021-10-30